Skip to main content
Clinical Trials/NCT00247468
NCT00247468
Withdrawn
Not Applicable

Strict Glucose Control of Pediatric ICU Patients to Reduce Mortality and Morbidity

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Respiratory Failure
Sponsor
Children's Hospital of Philadelphia
Primary Endpoint
30-day mortality rate from the time of enrollment
Status
Withdrawn
Last Updated
9 years ago

Overview

Brief Summary

The study objective is to improve morbidity and mortality of high-risk critically ill children. Our hypothesis is that a strict ICU glucose control protocol will decrease morbidity and mortality associated with hyperglycemia in a population of high-risk critically ill pediatric patients.

Registry
clinicaltrials.gov
Start Date
December 2004
End Date
December 2004
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Vasoactive infusion (e.g. dopamine, epinephrine, norepinephrine) and/or
  • Invasive mechanical ventilation
  • Age between 1 mo and 21 yrs

Exclusion Criteria

  • Type I diabetes mellitus
  • Have an illness that requires insulin daily
  • Recipients of solid organ transplants
  • Participation in an experimental trial that might affect outcome
  • Post-operative patients with planned extubation upon recovery
  • Patients on a dopamine infusion of less than 3 mcg/kg/minute

Outcomes

Primary Outcomes

30-day mortality rate from the time of enrollment

Secondary Outcomes

  • Pediatric Overall Performance Category scores at ICU discharge and 6 months post-discharge
  • rates of nosocomial bloodstream infections
  • time to resolution of organ failure (mechanical ventilator days and days of vasopressor support)
  • change in Pediatric Logistic Organ Dysfunction scores
  • requirement of dialysis or hemofiltration for patients with acute renal failure
  • volume of blood product transfusions per kilogram body weight (vol/kg).

Similar Trials